Jet Airways reported a disappointing set of numbers in Q2FY19 for the third consecutive quarter as its key performance parameters fell much short of the consensus estimates.
The revamped board of the beleaguered IL&FS has set the ball rolling to get the house in order by calling for stake sale in two of its subsidiaries - IL&FS Securities Services Ltd and ISSL Settlement & Transaction Services Limited.
Aurobindo Pharma entered into an agreement to purchase research and development assets from Australia based Advent Pharma, which deals in complex specialty generics. The total investment for this acquisition is pegged at $12.5 mn.
Oil India’s board to consider buyback on November 19. Company has gross cash and cash equivalents worth Rs5,253cr.
Cadila Healthcare clarified that on the news of “Kerala regulator finds three drugs of sub-standard quality” that Zipcet tablets were recalled by the company on June 29 and the batch was manufactured following current good manufacturing practices and released for sale only after batch meeting the pre-defined specifications, including dissolution.
Lupin announced the launch of Atovane Oral Suspension USP launches in the U.S., after having received an approval from USFDA earlier.
Shree Cements to add capacity in two plants located in Jharkhand and Odisha. The combined capacity addition will be 5.5 MTPA with a total investment of Rs903cr.
HCL Technologies announced partnership with NetBrain Technologies to offer network visibility and network automation capabilities for enterprise IT teams.
NBCC received order for construction of Ayurveda Institute in Goa for Rs260cr. The company also reported that it had secured a total business of Rs1,854cr for the month of October.
No comments:
Post a Comment